Arkadios Wealth Advisors Abbott Laboratories Transaction History

Arkadios Wealth Advisors

$1.64 Billion
Q3 2024

A detailed history of Arkadios Wealth Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Arkadios Wealth Advisors holds 15,651 shares of ABT stock, worth $1.79 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

15,651

Previous 11,890 31.63%

Holding current value

$1.79 Million

Previous $1.24 Million 44.45%

% of portfolio

0.11%

Previous 0.09%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$100.07 - $118.13 $376,363 - $444,286	3,761 Added 31.63%	15,651 $1.78 Million
Q2 2024 Jul 29, 2024	BUY	$100.73 - $112.44 $54,293 - $60,605	539 Added 4.75%	11,890 $1.24 Million
Q1 2024 Apr 30, 2024	SELL	$109.52 - $120.96 $151,466 - $167,287	-1,383 Reduced 10.86%	11,351 $1.29 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $78,014 - $95,496	865 Added 7.29%	12,734 $1.4 Million
Q3 2023 Oct 13, 2023	BUY	$95.53 - $114.62 $80,340 - $96,395	841 Added 7.63%	11,869 $1.15 Million
Q2 2023 Jul 26, 2023	SELL	$100.78 - $112.29 $84,453 - $94,099	-838 Reduced 7.06%	11,028 $1.2 Million
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $52,207 - $61,451	-539 Reduced 4.35%	11,866 $1.2 Million
Q4 2022 Jan 11, 2023	BUY	$95.06 - $111.52 $60,838 - $71,372	640 Added 5.44%	12,405 $0
Q3 2022 Oct 21, 2022	SELL	$96.76 - $112.03 $72,763 - $84,246	-752 Reduced 6.01%	11,765 $1.14 Million
Q2 2022 Jul 14, 2022	SELL	$102.07 - $123.37 $89,719 - $108,442	-879 Reduced 6.56%	12,517 $1.36 Million
Q1 2022 May 02, 2022	BUY	$114.02 - $139.04 $255,518 - $311,588	2,241 Added 20.09%	13,396 $1.59 Million
Q4 2021 Feb 03, 2022	BUY	$115.53 - $141.46 $43,323 - $53,047	375 Added 3.48%	11,155 $1.57 Million
Q3 2021 Oct 19, 2021	SELL	$116.66 - $129.06 $180,473 - $199,655	-1,547 Reduced 12.55%	10,780 $1.27 Million
Q2 2021 Jul 28, 2021	BUY	$105.79 - $124.53 $653,464 - $769,221	6,177 Added 100.44%	12,327 $1.43 Million
Q1 2021 Apr 26, 2021	BUY	$108.84 - $128.23 $76,079 - $89,632	699 Added 12.82%	6,150 $737,000
Q4 2020 Feb 09, 2021	SELL	$105.0 - $114.42 $25,410 - $27,689	-242 Reduced 4.25%	5,451 $596,000
Q3 2020 Nov 10, 2020	SELL	$91.64 - $111.29 $6,781 - $8,235	-74 Reduced 1.28%	5,693 $624 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $105,513 - $135,044	1,378 Added 31.4%	5,767 $547 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $76,514 - $111,885	1,218 Added 38.41%	4,389 $346 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $248,955 - $277,145	3,171 New	3,171 $275,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Arkadios Wealth Advisors with notifications on news.

Account

Arkadios Wealth Advisors Abbott Laboratories Transaction History